Prudential Financial Inc Allogene Therapeutics, Inc. Transaction History
Prudential Financial Inc
- $80 Billion
- Q3 2025
A detailed history of Prudential Financial Inc transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 15,930 shares of ALLO stock, worth $19,116. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,930
Previous 15,930
-0.0%
Holding current value
$19,116
Previous $18,000
5.56%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ALLO
# of Institutions
175Shares Held
146MCall Options Held
122KPut Options Held
36.3K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$22.5 Million1.5% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$19.7 Million0.0% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$12.6 Million0.5% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il10.3MShares$12.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.02MShares$10.8 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $173M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...